BARCLAYS PLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 174 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2019. The put-call ratio across all filers is 0.44 and the average weighting 1.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$32,971,000
+104.3%
218,095
+96.9%
0.04%
+260.0%
Q2 2022$16,135,000
+1317.8%
110,743
+1053.9%
0.01%
+900.0%
Q1 2022$1,138,000
-93.9%
9,597
-92.9%
0.00%
-66.7%
Q4 2021$18,632,000
+487.0%
135,210
+491.8%
0.00%
+200.0%
Q3 2021$3,174,000
+284.3%
22,849
+168.4%
0.00%
Q2 2021$826,000
-70.0%
8,514
-78.8%
0.00%
-100.0%
Q1 2021$2,752,000
-77.1%
40,248
-71.3%
0.00%
-83.3%
Q4 2020$12,036,000
+735.3%
140,437
+533.1%
0.01%
+500.0%
Q3 2020$1,441,000
-36.7%
22,183
-28.8%
0.00%
-50.0%
Q2 2020$2,277,000
-66.4%
31,144
-84.4%
0.00%
-60.0%
Q1 2020$6,785,000
-34.6%
199,404
+4.6%
0.01%
-16.7%
Q4 2019$10,382,000
+1191.3%
190,693
+889.0%
0.01%
+500.0%
Q3 2019$804,000
-76.4%
19,281
-75.2%
0.00%
-66.7%
Q2 2019$3,402,000
+0.9%
77,672
+18.5%
0.00%
+50.0%
Q1 2019$3,373,000
+28008.3%
65,545
+20192.6%
0.00%
Q4 2018$12,000
-97.6%
323
-97.5%
0.00%
Q3 2018$492,000
+8.8%
13,107
+14.5%
0.00%
Q2 2018$452,000
-93.9%
11,446
-96.0%
0.00%
-100.0%
Q1 2018$7,431,000
+8540.7%
288,451
+8962.2%
0.01%
Q4 2017$86,000
+59.3%
3,183
+120.7%
0.00%
Q3 2017$54,0001,442
+17925.0%
0.00%
Q2 2017$080.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q1 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
UBS OCONNOR LLC 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders